PROS1 and non-small cell lung carcinoma: First, tumor explants were generated from fresh biopsies isolated from NSCLC patients, cultured ex vivo on matched tumor matrix proteins supplemented with autologous patient plasma, and exposed to various clinically-relevant drug regimens (Fig 6a and S3 Table).